Skip to main content

Table 1 Demographic, clinical and biochemical characteristics of study participants stratified by clinical conditions

From: Prevalence of chronic kidney disease among the high risk population in South-Western Ghana; a cross sectional study

Variable Diabetes (n = 120) Hypertension (n = 65) Hypertension and diabetes (n = 23) P-value
Age (years) 60.2 ± 10.1 60.8 ± 9.5 60.7 ± 8.6 0.913
Age group (years)
  < 40 5 (4.2) 1 (1.5) 0 (0.0)  
 40–49 11 (9.2) 8 (12.3) 1 (4.3)  
 50–59 38 (31.7) 16 (24.6) 9 (39.1)  
 60–69 44 (36.7) 27 (41.5) 9 (39.1)  
  ≥ 70 22 (18.3) 13 (20.0) 4 (17.4)  
Sex
 Male 32 (26.7) 21 (32.3) 7 (30.4)  
 Female 88 (73.3) 44 (67.7) 16 (69.6) 0.795
Disease Duration (years) 5.4 ± 2.4 5.2 ± 2.3 6.3 ± 3.4 0.192
Disease Duration Category
  < 5 51 (42.5) 30 (46.2) 8 (34.8)  
 5–10 65 (54.2) 32 (49.2) 13 (56.5)  
  > 10 4 (3.3) 3 (4.6) 2 (8.7) 0.721
FBG (mmol/l) 9.7 ± 3.7 5.8 ± 1.4 13.4 ± 4.7 <0.001
SBP (mmHg) 130.3 ± 15.1 145.7 ± 22.8 160.0 ± 17.8 <0.001
DBP (mmHg) 75.1 ± 8.7 85.2 ± 10.2 94.8 ± 12.0 <0.001
BMI (kg/m2) 27.5 ± 5.2 27.4 ± 5.0 27.7 ± 5.6 0.966
BMI Category n(%)
 Underweight 3 (2.5) 1 (1.5) 0 (0.0)  
 Normal 34 (28.3) 19 (29.2) 10 (43.5)  
 Overweight 48 (40.0) 29 (44.6) 6 (26.1)  
 Obese 35 (29.2) 16 (24.6) 7 (30.4) 0.672
eGFR, mL/min/1.73 m2 82 ± 32 76 ± 26 61 ± 39 0.012
  1. FBG fasting blood glucose, BMI body mass index, ACE angiotensin converting enzyme, eGFR estimated glomerular filtration rate